IDV vehicle
36E79724A0028
BPA FOR XYREM, XYWAV
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79719D0205 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $161.2M |
| Start date | Aug 16, 2024 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Jul 7, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 9 of 9 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 7, 2026 | P00009 | $0 | EXERCISE OPTION YEAR 2 - BPA 36E79724A0028 |
| May 5, 2026 | P00008 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE A PRICE INCREASE TO 1 MODEYSO NDC ON BPA 36E79724A0028. |
| Jan 15, 2026 | P00007 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE A TPR TO AN EXISTING XYWAV NDC ON BPA 36E79724A0028. |
| Nov 13, 2025 | P00006 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE PUBLIC LAW PRICING UPDATE 2026. |
| Oct 20, 2025 | P00005 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE PRODUCT DELETION OF 1 NDC TO BPA 36E797240028. |
| Sep 23, 2025 | P00004 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE PRODUCT ADDITION OF 1 NDC TO BPA 36E797240028. |
| Jun 4, 2025 | P00003 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 1 ON BPA 36E797240028. |
| Dec 23, 2024 | P00002 | $0 | 2025 TEMPORARY PRICE REDUCTION (TPR). |
| Dec 10, 2024 | P00001 | $0 | 2025 PUBLIC LAW PRICING UPDATES. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.